Dong-yu Wang

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.

Journal: Cell reports
Published: November 05, 2025

TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progression.

TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progression.

Journal: British journal of cancer
Published: September 19, 2025

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Journal: Cancers
Published: January 13, 2025

Thinking (Metastasis) outside the (Primary Tumor) Box.

Thinking (Metastasis) outside the (Primary Tumor) Box.

Journal: Cancers
Published: October 30, 2023

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer.

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer.

Journal: Oncogenesis
Published: January 02, 2023

Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.

Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.

Journal: Nature communications
Published: June 22, 2022

Stratifying the stratifiers of triple negative breast cancer.

Stratifying the stratifiers of triple negative breast cancer.

Journal: Oncotarget
Published: January 01, 2020

Molecular stratification within triple-negative breast cancer subtypes.

Molecular stratification within triple-negative breast cancer subtypes.

Journal: Scientific reports
Published: August 07, 2019

Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.

Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.

Journal: Nature communications
Published: January 02, 2019

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.

Journal: Breast cancer research : BCR
Published: August 20, 2018

CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead.

CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead.

Journal: Molecular & cellular oncology
Published: May 16, 2018

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.

Journal: Cell reports
Published: October 23, 2017
Showing 1-12 of 17

Last Updated: 09/26/2026